Effect of age on the efficacy and safety of lenvatinib for the treatment of 131i-refractory differentiated thyroid cancer in the phase 3 select study

Authors

• M S. Brose

Publication/Presentation Date

10-2014

Volume

5

Issue

2

First Page

22

Last Page

23

Published In/Presented At

https://doi.org/10.1016/j.jgo.2014.09.171

Disciplines

Medicine and Health Sciences

Department(s)

Hematology-Medical Oncology Division

Document Type

Article